As the U.S. stock market navigates a period of mixed performance, with major indices like the Dow Jones and S&P 500 experiencing fluctuations amid economic uncertainties and tariff concerns, investors ...
Zacks Investment Research on MSN18h
PODD Stock to Gain From Favorable RADIANT Trial Results for Omnipod 5Insulet Corporation PODD announced favorable RADIANT trial clinical data for its Omnipod 5 at the 18th International Conference on Advanced Technologies and Treatments for Diabetes (“ATTD”). Omnipod 5 ...
Individuals transitioning from multiple daily injections to the Omnipod 5 system experienced an average HbA1c reduction of ...
Medical device companies presented new data this week at the Advanced Technologies & Treatments for Diabetes conference.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback